| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| ACCOUNTING & TAX PREPARATION FEES | 17,485 | 0 | 17,485 |
| Grantee's Name | Grantee's Address | Grant Date | Grant Amount | Grant Purpose | Amount Expended By Grantee | Any Diversion By Grantee? | Dates of Reports By Grantee | Date of Verification | Results of Verification |
|---|---|---|---|---|---|---|---|---|---|
|
NONINVASIX INC |
1700 THE STRAND SUITE 1200 GALVESTON,TX77555 |
2017-07-27 | 7,000 | TO FUND NONINVASIX'S PARTICIPATION IN THE PHILIPS' MATERNAL AND INFANT HEALTHWORKS START-UP PROGRAM. | 7,000 | NONE, SEE BELOW | PRI REPORTS - 2/21/18, 4/20/18, 9/30/18, 2/14/19 | 2017-12-15 | THE TRUSTEES MEET WITH NONIVASIX MANAGEMENT ON A REGULAR BAS1S, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY |
|
BREEGI SCIENTIFIC INC |
120 BEDFORD ROAD WOBURN,MA01801 |
2017-06-26 | 250,000 | THE FUNDS WILL BE USED TO CONDUCT A THOROUGH CLINICAL ASSESSMENT OF BSI'S NOVEL NEONATAL INTENSIVE CARE INCUBATOR "(NICI)" IN HONDURAS AND ZAMBIA AND TO AID THE COMMERCIALIZATION EFFORTS OF THIS LIFE-SAVING MEDICAL DEVICE. | 58,927 | NONE, SEE BELOW | PRI REPORTS - 2/8/18, 5/14/18, 7/15/18, 9/15/18, 10/31/18, 12/7/18, 12/11/18 | 2019-05-16 | THE TRUSTEES MEET WITH BREEGI SCIENTIFIC, INC. MANAGEMENT ON A REGULAR BASIS AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY |
|
NONINVASIX INC |
1700 THE STRAND SUITE 1200 GALVESTON,TX77555 |
2015-12-30 | 150,000 | TO SUPPORT THE USE AND DEVELOPMENT OF THE COMPANY'S PEDIATRIC BRAIN OXYGENATION MONITORING SYSTEM, WHICH HAS THE POTENTIAL TO MORE ACCURATELY ASSESS THE RISK OF BRAIN HYPOXIA IN FETUSES AND NEONATES, THEREBY SUPPORTING THE ADVANCEMENT OF SCIENCE AND LESSENING THE BURDEN OF THE GOVERNMENT. | 150,000 | NONE, SEE BELOW | PRI REPORTS - 2/21/18, 4/20/18, 9/30/18, 2/14/19 | 2017-12-15 | THE TRUSTEES MEET WITH NONIVASIX MANAGEMENT ON A REGULAR BAS1S, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY |
|
ALDATU BIOSCIENCES |
C/O HARVARD LIFELAB 127 WESTERN AVE ALLSTON,MA02134 |
2016-02-23 | 100,000 | TO SUPPORT THE USE AND DEVELOPMENT OF A SIMPLE, RAPID, THERMOSTABLE KIT THAT IDENTIFIES CLINICALLY ACTIONABLE HIV MUTATIONS FOUND IN PATIENTS FAILING A FIRST-LINE DRUG REGIMEN, THEREBY SUPPORTING THE ADVANCEMENT OF SCIENCE AND RELIEF OF THE POOR, DISTRESSED AND UNDERPRIVILEGED. | 100,000 | NONE, SEE BELOW | PRI REPORTS - 2/6/18, 5/22/18, 6/26/18, 1/15/19 | 2017-12-15 | THE TRUSTEES MEET WITH ALDATU BIOSCIENCE, INC. MANAGEMENT ON A REGULAR BASIS AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY. |
|
NONINVASIXINC |
1700 THE STRAND SUITE 1200 GALVESTON,TX77555 |
2016-07-26 | 150,000 | TO SUPPORT THE USE AND DEVELOPMENT OF THE COMPANY'S PEDIATRIC BRAIN OXYGENATION MONITORING SYSTEM, WHICH HAS THE POTENTIAL TO MORE ACCURATELY ASSESS THE RISK OF BRAIN HYPOXIA IN FETUSES AND NEONATES, THEREBY SUPPORTING THE ADVANCEMENT OF SCIENCE AND LESSENING THE BURDEN OF THE GOVERNMENT. | 150,000 | NONE, SEE BELOW | PRI REPORT - 2/21/18, 4/20/18, 9/30/18, 2/14/19 | 2017-12-15 | THE TRUSTEES MEET WITH NONIVASIX MANAGEMENT ON A REGULAR BAS1S, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY |
|
THINKMD INC |
166 MAIN STREET BURLINGTON,VT05401 |
2018-05-18 | 150,000 | FOR DEVELOPING INTEGRATED CLINICAL ASSESSMENT AND DATA ANALYTICS PLATFORMS AND OTHER DERIVATIVE PRODUCTS THAT TRANSFORM POINT-OF-CARE MEDICINE BY PUTTING VALIDATED CLINICAL ASSESSMENT CAPABILITY AND INCREASED HEALTHCARE KNOWLEDGE INTO THE HANDS OF CLINICALLY UNTRAINED HEALTHCARE PROFESSIONALS AND FAMILIES. | 150,000 | NONE, SEE BELOW | PRI REPORTS - 7/12/18, 8/17/18, 10/2/18, 11/6/18, 12/31/18, 2/11/19 | 2019-02-11 | THE TRUSTEES MEET WITH THINKMD MANAGEMENT ON A REGULAR BAS1S, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY. |
|
PRAPELA LLC |
625 LOWELL ROAD CONCORD,MA01742 |
2018-07-02 | 250,000 | THE PROCEEDS OF THE SALE AND ISSUANCE OF THE NOTES SHALL BE USED ONLY TO SUPPORT THE USE AND DEVELOPMENT OF THE COMPANY'S SLEEP TECH. | 178,788 | NONE, SEE BELOW | PRI REPORTS - 7/19/18, 12/10/18, 1/30/19, 2/24/19 | 2019-05-14 | THE TRUSTEES MEET WITH THINKMD MANAGEMENT ON A REGULAR BAS1S, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY. |
| Name of Bond | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| FIXED INCOME | 7,042,568 | 7,042,568 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| DOMESTIC EQUITIES | 15,193,116 | 15,193,116 |
| FOREIGN SECURITIES | 3,486,536 | 3,486,536 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| REAL ESTATE | FMV | 1,156,804 | 1,156,804 |
| ALTERNATIVE INVESTMENTS | FMV | 231,333 | 231,333 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| LEGAL EXPENSES | 12,092 | 0 | 12,092 |
| Description | Beginning of Year - Book Value | End of Year - Book Value | End of Year - Fair Market Value |
|---|---|---|---|
| PROGRAM RELATED INVESTMENTS | 657,000 | 1,057,000 | 1,057,000 |
| Description | Amount |
|---|---|
| UNREALIZED LOSSES | 20,239,856 |
| LOSS ON INVESTMENT IN GPG HEALTHCARE OPPORTUNITIES FUND, LLC | 13,286 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| MASS PC FILING FEE | 1,045 | 0 | 1,045 | |
| MISCELLANEOUS EXPENSES | 6,842 | 0 | 6,842 | |
| HRIA ADMINISTRATIVE COSTS | 142,820 | 0 | 142,820 | |
| MEMBERSHIPS | 4,306 | 0 | 4,306 | |
| PROGRAM RELATED INVESTMENT ADMINISTRATIVE COSTS | 23,172 | 0 | 23,172 | |
| MARKETING | 11,349 | 0 | 11,349 | |
| 75TH ANNIVERSARY EVENT | 1,315 | 0 | 1,315 | |
| HONORARIA | 20,344 | 0 | 20,344 | |
| SCIENTIFIC ADVISORS | 16,050 | 0 | 16,050 |
| Description | Revenue And Expenses Per Books | Net Investment Income | Adjusted Net Income |
|---|---|---|---|
| SETTLEMENT PROCEEDS | 7,308 | 7,308 | |
| RETURNED GRANT FUNDS | 34,480 | 34,480 | |
| NONDIVIDEND DISTRIBUTIONS | 47,596 | 47,596 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| INVESTMENT ADVISORY FEES - STATE STREET | 63,925 | 63,925 | 0 | |
| INVESTMENT FEES - US TRUST | 135,138 | 67,569 | 67,569 | |
| INVESTMENT CONSULTING | 37,500 | 37,500 | 0 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| FOREIGN TAXES | 35,453 | 35,453 | 0 | |
| EXCISE TAX ESTIMATES | 218,500 | 0 | 0 |